Literature DB >> 9238407

Adjustment of ECG left ventricular hypertrophy criteria for body mass index and age improves classification accuracy. The effects of hypertension and obesity.

J E Norman1, D Levy.   

Abstract

Population-based data from the Framingham Heart Study have served as the basis for adjusting electrocardiographic (ECG) criteria for echocardiographically determined left ventricular hypertrophy (LVH) for two determinants of their sensitivity: body mass index and age. Estimated regression equations that predict echo-derived left ventricular mass from an ECG LVH voltage criterion, body mass index, and age, for 1,468 men and 1,883 women, provide a simple and effective means of adjusting that criterion for these variables. The authors evaluated five different ECG LVH criteria, comparing the performances of their original and adjusted versions within this database. All adjusted criteria significantly outperformed their unadjusted counterparts. Of these five criteria, the Cornell voltage duration product, (RAVL + SV3). QRS interval, exhibited the greatest sensitivity at all levels of specificity for both sexes (39 and 51% sensitivity at 95% specificity in men and women, respectively). Its performance was further evaluated with separate adjustment algorithms developed for lean versus obese and normotensive versus hypertensive men and women. Age and body mass index adjustment produced significant improvements for both lean and obese women and for obese men. A marginal gain in sensitivity was found in lean normotensive men. Within the relatively small subgroup of lean hypertensive men, no improvement was observed. These results suggest that among Caucasian adults, the Cornell voltage duration product adjusted for body mass index and age offers significant improvement for the detection of echocardiographically determined LVH in all but lean men; within the latter group, it loses no sensitivity in comparison with the original criterion.

Entities:  

Mesh:

Year:  1996        PMID: 9238407     DOI: 10.1016/s0022-0736(96)80070-7

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  10 in total

1.  Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.

Authors:  Veerawat Nomsawadi; Rungroj Krittayaphong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

2.  Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Shinpei Kadowaki; Taro Narumi; Yuki Honda; Hiromasa Hasegawa; Shintaro Honda; Akira Funayama; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takehiko Miyashita; Takuya Miyamoto; Isao Kubota
Journal:  Clin Res Cardiol       Date:  2013-12-01       Impact factor: 5.460

Review 3.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

4.  Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population?

Authors:  Cesare Cuspidi; Rita Facchetti; Michele Bombelli; Carla Sala; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-23       Impact factor: 3.738

5.  Deep Learning to Predict Cardiac Magnetic Resonance-Derived Left Ventricular Mass and Hypertrophy From 12-Lead ECGs.

Authors:  Shaan Khurshid; Samuel Friedman; James P Pirruccello; Paolo Di Achille; Nathaniel Diamant; Christopher D Anderson; Patrick T Ellinor; Puneet Batra; Jennifer E Ho; Anthony A Philippakis; Steven A Lubitz
Journal:  Circ Cardiovasc Imaging       Date:  2021-06-15       Impact factor: 8.589

6.  Improvements in ECG accuracy for diagnosis of left ventricular hypertrophy in obesity.

Authors:  Oliver J Rider; Ntobeko Ntusi; Sacha C Bull; Richard Nethononda; Vanessa Ferreira; Cameron J Holloway; David Holdsworth; Masliza Mahmod; Jennifer J Rayner; Rajarshi Banerjee; Saul Myerson; Hugh Watkins; Stefan Neubauer
Journal:  Heart       Date:  2016-08-02       Impact factor: 5.994

7.  Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.

Authors:  Sanne M Snelder; Sweder W E van de Poll; Lotte E de Groot-de Laat; Isabella Kardys; Felix Zijlstra; Bas M van Dalen
Journal:  Clin Cardiol       Date:  2020-01-28       Impact factor: 2.882

8.  Are there height-dependent differences in subclinical vascular disease in hypertensive patients?

Authors:  Caterina Ferriol; Susanna Tremols; Carmen Jimenez; Anna Tura; Maria Sanmartín; Núria Pagès; Antonio Rodríguez-Poncelas; Marco Paz-Bermejo; Marc Saez; Gabriel Coll-de-Tuero
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-11-05       Impact factor: 3.738

9.  Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population.

Authors:  Ahmadou M Jingi; Jean Jacques N Noubiap; Philippe Kamdem; Samuel Kingue
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

10.  Electrocardiographic Detection of Left Ventricular Hypertrophy; Adding Body Mass Index and Spatial QRS-T Angle: A Cross-Sectional Study.

Authors:  Theodora W Elffers; Stella Trompet; Renée de Mutsert; Arie C Maan; Hildo J Lamb; Peter W Macfarlane; Frits R Rosendaal; J Wouter Jukema
Journal:  Cardiol Ther       Date:  2019-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.